Navigation Links
CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
Date:4/3/2008

-Company Joins Supplier Base Offering Broad Array of Healthcare Products to

Patients with Immune Deficiency and Bleeding Disorders

OTTAWA, April 3, 2008 /PRNewswire/ -- CSL Behring Canada, Inc. today announced that Canadian Blood Services, and Hema-Quebec, have each awarded the company contracts to supply Helixate(R) FS (Antihemophilic Factor [Recombinant]), Humate(R) P (Antihemophilic factor / von Willebrand Factor Complex [Human], Dried, Pasteurized), Privigen (Immune Globulin Intravenous [Human]), Vivaglobin(R) (Immune Globulin Subcutaneous [Human]) and other plasma-derived products. These products are used for the treatment of conditions such as hemophilia, von Willebrand Disease, primary immunodeficiency as well as other serious conditions.

The contracts call for CSL Behring to supply the above mentioned life-saving therapies over a period of at least five years, and to provide toll manufacturing services to Canadian Blood Services for the fractionation of Canadian plasma. In addition, with this agreement, CSL Behring will become the main supplier of bleeding disorder treatments in the province of Quebec.

CSL Behring currently maintains a portfolio of 23 different products, which it develops, manufactures, and distributes to the global healthcare community. The company also offers comprehensive consumer support, research and education support, disease awareness campaigns and other initiatives to ensure that patients receive proper diagnoses and treatment interventions.

"We at CSL Behring in Canada are quite pleased with the awards," said Dr. Heinz Neuhaus, General Manager of CSL Behring Canada. "Our company has made significant investments in becoming a reliable partner for both Canadian Blood Services and Hema-Quebec so that we can expand our product offering to Canadian patients in need. It is gratifying to be recognized with a supply agreement that allows us to strengthen even further our commitment to saving and i
'/>"/>

SOURCE CSL Behring
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. CSL Behring Expands Into Middle East Market with Haemate(R) P
2. Siemens Completes Acquisition of Dade Behring
3. Siemens Receives EU Antitrust Clearance for Acquisition of Dade Behring
4. AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
5. Pharsight Signs Two New DMX(R) License Customers
6. Siemens Signs Multi-Year Agreement With Cleveland Clinic to Deploy Enterprise-Wide Cardiology PACS
7. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
8. Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
9. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
10. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
11. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...all/ -- BioSpecifics Technologies Corp. (Nasdaq: ...st-in-class collagenase-based products, today anno...ended September 30, 2009. ,, "We were extremel... Arthritis Advisory Committee unanimously recommen...) for the treatment of Dupuytren,s disease, and we...
(Date:11/5/2009)...re-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a...or-based technologies to discover novel flavor ing...pply industries, today provided a corporate update...ter ended September 30, 2009. Revenues were $4.2 ... $4.0 million for the third quarter of 2008, an in...
(Date:11/5/2009)...wire-Asia-FirstCall/ -- BMP Sunstone,Corporation (...today announced,that the Company plans to release ...vember 9, 2009, after the market closes. , ...pm ET on November 9, 2009,to discuss third quarter...ialing 1-888-713-4211 or 1-617-213-4864 for intern...
(Date:11/5/2009)... a new look to Pro Repro , ...nal Reprographics, Orange County’s fastest g... Brooke Sanders to the company. Brooke joins the c...on of Brooke to the company represents continued a...hics., , ,Brooke brings with her over five years o...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
... This week, I want to test a theory. In short, asp...onspiring to cause the migration of technology-cen...nology centers such as Silicon Valley and Boston t...he resulting infusion into those areas of new bloo..., and (potentially) new capital, will inspire a re...
... Chicago, IL - The recent Chicago biotech festiva...linois is finally coming of age. , ,That same wee...on (IBIO) elected as its new chairman Jim L. Tyr...and licensing at Abbott Laboratories (not to be...gnificant because it means Abbott is stepping up t...
... CHICAGO The Midwest has been approached by a var...nterest in developing ties between regional biotec...ss ,2. The Germans ,3. The Irish ,4. The Taiwanese...ish , ,None, however, have taken biotech more ser...,In at least two previous columns, you have seen m...
Other Biology Technology:The Milkweed Effect: Disseminating Technology to New Regions 2The Milkweed Effect: Disseminating Technology to New Regions 3The Milkweed Effect: Disseminating Technology to New Regions 4Abbott Executive Jim Tyree Takes IBIO Helm 2Abbott Executive Jim Tyree Takes IBIO Helm 3Abbott Executive Jim Tyree Takes IBIO Helm 4Abbott Executive Jim Tyree Takes IBIO Helm 5Abbott Executive Jim Tyree Takes IBIO Helm 6Abbott Executive Jim Tyree Takes IBIO Helm 7Abbott Executive Jim Tyree Takes IBIO Helm 8Japanese Continue Relentless Biotech Stake in Midwest 2Japanese Continue Relentless Biotech Stake in Midwest 3Japanese Continue Relentless Biotech Stake in Midwest 4Japanese Continue Relentless Biotech Stake in Midwest 5Japanese Continue Relentless Biotech Stake in Midwest 6Japanese Continue Relentless Biotech Stake in Midwest 7Japanese Continue Relentless Biotech Stake in Midwest 8Japanese Continue Relentless Biotech Stake in Midwest 9
(Date:11/4/2009)... Aware, Inc. (Nasdaq: A...and biometrics software, today reported financial ... 2009. ,, Michael Tzannes, Aware,s Chairman a...we announced an agreement to sell our DSL and home... semiconductor company being spun out of Infineon....
(Date:11/4/2009)...sts at the University of North Carolina at Chapel ...fornia, San Francisco have developed and experimen...eases for existing drugs. , The researchers deve...ilar the structures of all known drugs are to the ...igands -- of disease targets within the cell. In a...
(Date:11/3/2009)...ultimate loner of the ocean, cruising thousands of...rs has discovered that the sharks have maintained ...ens of thousands of years the white sharks in the ...es into a population genetically distinct from sha...a large, highly mobile species," said Salvador Jor...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 1Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 2Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 3Public Health Faith Leaders Call on DC Council to Renew Funding for Successful Tobacco Prevention Programs 57025 4SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 1SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 2SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 3SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 4SXC Health Solutions teams with Allscripts to deliver critical prescription information to physicians at the point of care 57023 5Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting 4997 1Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting 4997 2Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting 4997 3Late Breaking Clinical Trials Presented at HFSA 13th Annual Scientific Meeting 4997 4
...ne and related compounds beginning in early adulth...types of cancer, researchers from Wake Forest Univ...ed today at ENDO 2005, the annual meeting of the E...rowth hormone and insulin-like growth factor (IGF-...als at high risk for disease, and perhaps could be...
...ia, San Diego biochemists has discovered the mecha...llion varieties of a single protein, a finding tha... the September 18 advance on-line publication of t..., the researchers describe the mechanism by which ...age, or phage--can generate a kaleidoscope of vari...
...rs of one family of antibiotics kill bacteria that...drug developers make slight changes to these antib...sistant strains of bacteria, said Irina Artsimovit...f microbiology at Ohio State University. , The ant...ntil now, researchers believed that these antibiot...
Other Biology News:Suppressing growth hormone in early adulthood may prevent cancer 2UCSD discovery may provide novel method to generate medically useful proteins 2UCSD discovery may provide novel method to generate medically useful proteins 3Researchers find how some antibiotics kill bacteria 2Researchers find how some antibiotics kill bacteria 3
.... Optimized for the rapid and efficient cloning of...es traditional TA cloning approaches by offering c...any as 25-fold more positive clones.Amplicons gene...e fully compatible.High efficiency cloning, no req...
GeneAmp High Fidelity PCR from Applied Biosystems
Guanylate Cyclase Blocking Peptide from Cayman Chemical
Expansion and Cryopreservation of Cells from Meridian Life Science, Inc.
Biology Products: